Citations

Showing 10 of 108104 citations.

Data Analytics of Electronic Medical Record to Study Racial Diversities in Cardiovascular Diagnosis and Treatment
Panahiazar, Maryam , Chern, Yorick, Riojas, Ramon , Latif, Omar, Hadley, Dexter , Beygui, Ramin E. , Latif, Omar S

Mayo Clinic

Studies in Health Technology and Informatics | May 25, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti220519 | PMID 35612140 Get It

The study of precision medicine that measures the effects of social, cultural, and environmental influences on health is essential to improve health outcomes. Race is a social concept used historically to divide, track, control populations, and reinforce social hierarchies. Beyond genetics, race is also a surrogate for other socioeconomic factors affecting patient outcomes. Our data analytics study aims to analyze the Electronic Medical Record (EMR) to study patients of different races in diagnosing and treating Coronary Artery Disease (CAD). We found no race discrepancies at the University of California San Francisco Medical Centers. This study opens several new hypotheses for further research in this crucial field.
Causal Associations Among Diseases and Imaging Findings in Radiology Reports
Sebro, Ronnie , Kahn, Charles E.

Mayo Clinic

Studies in Health Technology and Informatics | May 25, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti220487 | PMID 35612109 Get It

This study explored the ability to identify causal relationships between diseases and imaging findings from their co-occurrences in radiology reports. A natural language processing (NLP) system with negative-expression filtering detected positive mentions of 16,912 disorders, interventions, and imaging findings in 1,702,462 consecutive radiology reports; the 55,564 causal relations defined by the Radiology Gamuts Ontology (RGO) served as reference standard. Conditions were considered to co-occur if they were present in reports from the same patient. The ϕ and κ statistics both achieved AUC0.70, P<0.001 in identifying causal relationships from pairwise co-occurrence data. Analysis of radiology reports can identify a large proportion of known causal associations among diseases and imaging findings. Automated approaches hold promise to identify causal relationships among diseases and imaging findings from their co-occurrence in text-based radiology reports.
An Ontology for Cardiothoracic Surgical Education and Clinical Data Analytics
Panahiazar, Maryam , Chern, Yorick, Riojas, Ramon , Latif, Omar, Lokala, Usha , Hadley, Dexter , Sheth, Amit , Beygui, Ramin E. , Latif, Omar S

Mayo Clinic

Studies in Health Technology and Informatics | May 25, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti220485 | PMID 35612107 Get It

The development of an ontology facilitates the organization of the variety of concepts used to describe different terms in different resources. The proposed ontology will facilitate the study of cardiothoracic surgical education and data analytics in electronic medical records (EMR) with the standard vocabulary.
Proteomics of Coagulopathy Following Injury Reveals Limitations of Using Laboratory Assessment to Define Trauma-Induced Coagulopathy to Predict Massive Transfusion
Moore, Hunter B. , Bertolet, Marnie , Barrett, Christopher D. , Bird, Molly A. , Moore, Ernest E. , Sperry, Jason L., Zuckerbraun, Brian S. , Park, Myung S., Cohen, Mitchell J. , Morrissey, James H. , Investigators, TACTIC, Neal, Matthew D , Joughin, Brian A. , Yaffe, Michael B. , Tracy, Russell P. , Wisniewski, Stephen R. , Investigators, TACTIC

Mayo Clinic

Annals of Surgery Open | May 25, 2022 | Volume: 3 | Issue: 2 | Pages: e167

10.1097/as9.0000000000000167 | PMID 36177090 Get It

Objective: Trauma-induced coagulopathy (TIC) is provoked by multiple mechanisms and is perceived to be one driver of massive transfusions (MT). Single laboratory values using prothrombin time (INR) or thrombelastography (TEG) are used to clinically define this complex process. We used a proteomics approach to test whether current definitions of TIC (INR, TEG, or clinical judgment) are sufficient to capture the majority of protein changes associated with MT. Methods: Eight level I trauma centers contributed blood samples from patients available early after injury. TIC was defined as INR >1.5 (INR-TIC), TEG maximum amplitude <50 mm (TEG-TIC), or clinical judgment (Clin-TIC) by the trauma surgeon. MT was defined as >10 units of red blood cells in 24 hours or >4 units RBC/hour during the first 4 hours. SomaLogic proteomic analysis of 1305 proteins was performed. Pathways associated with proteins dysregulated in patients with each TIC definition and MT were identified. Results: Patients (n = 211) had a mean injury severity score of 24, with a MT and mortality rate of 22% and 12%, respectively. We identified 578 SOMAscan analytes dysregulated among MT patients, of which INR-TIC, TEG-TIC, and Clin-TIC patients showed dysregulation only in 25%, 3%, and 4% of these, respectively. TIC definitions jointly failed to show changes in 73% of the protein levels associated with MT, and failed to identify 26% of patients that received a massive transfusion. INR-TIC and TEG-TIC patients showed dysregulation of proteins significantly associated with complement activity. Proteins dysregulated in Clin-TIC or massive transfusion patients were not significantly associated with any pathway. Conclusion: These data indicate there are unexplored opportunities to identify patients at risk for massive bleeding. Only a small subset of proteins that are dysregulated in patients receiving MT are statistically significantly dysregulated among patients whose TIC is defined based solely on laboratory measurements or clinical assessment.
Faculty Opinions recommendation of Intrathecal bupivacaine versus chloroprocaine for transvaginal cervical cerclage placement: a retrospective cohort study.
Sviggum, Hans P.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 25, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.741766858.793593172 Get It

Distinct Phenotypes of Kidney Transplant Recipients in the United States with Limited Functional Status as Identified through Machine Learning Consensus Clustering
Jadlowiec, Caroline C. , Kaewput, Wisit , Vaitla, Pradeep , Mao, Shennen A. , Mao, Michael A. , Leeaphorn, Napat , Pattharanitima, Pattharawin , Qureshi, Fahad , Acharya, Prakrati , Cooper, Matthew , Cheungpasitporn, Wisit , Jadlowiec, Caroline , Kaewput, Wisit , Mao, Shennen A , Mao, Michael A , Pattharanitima, Pattharawin , Qureshi, Fahad , Cooper, Matthew , Cheungpasitporn, Wisit , Thongprayoon, Charat , Qureshi, Fawad , Nissaisorakarn, Pitchaphon

Mayo Clinic

Journal of Personalized Medicine | May 25, 2022 | Volume: 12 | Issue: 6 | Pages: 859

10.3390/jpm12060859 | PMID 35743647 Get It

Background: There have been concerns regarding increased perioperative mortality, length of hospital stay, and rates of graft loss in kidney transplant recipients with functional limitations. The application of machine learning consensus clustering approach may provide a novel understanding of unique phenotypes of functionally limited kidney transplant recipients with distinct outcomes in order to identify strategies to improve outcomes. Methods: Consensus cluster analysis was performed based on recipient-, donor-, and transplant-related characteristics in 3205 functionally limited kidney transplant recipients (Karnofsky Performance Scale (KPS) < 40% at transplant) in the OPTN/UNOS database from 2010 to 2019. Each cluster’s key characteristics were identified using the standardized mean difference. Posttransplant outcomes, including death-censored graft failure, patient death, and acute allograft rejection were compared among the clusters Results: Consensus cluster analysis identified two distinct clusters that best represented the clinical characteristics of kidney transplant recipients with limited functional status prior to transplant. Cluster 1 patients were older in age and were more likely to receive deceased donor kidney transplant with a higher number of HLA mismatches. In contrast, cluster 2 patients were younger, had shorter dialysis duration, were more likely to be retransplants, and were more likely to receive living donor kidney transplants from HLA mismatched donors. As such, cluster 2 recipients had a higher PRA, less cold ischemia time, and lower proportion of machine-perfused kidneys. Despite having a low KPS, 5-year patient survival was 79.1 and 83.9% for clusters 1 and 2; 5-year death-censored graft survival was 86.9 and 91.9%. Cluster 1 had lower death-censored graft survival and patient survival but higher acute rejection, compared to cluster 2. Conclusion: Our study used an unsupervised machine learning approach to characterize kidney transplant recipients with limited functional status into two clinically distinct clusters with differing posttransplant outcomes.
Twice as nice: Cytomegalovirus tele‐education
Garson, Jennifer T. , Bernard, Stacy A. , Deziel, Paul J. , Lemke, Adley , Rivera, Christina G. , Razonable, Raymund R. , Lemke, Adley I, Razonable, Raymund R , Rivera, Christina G

Mayo Clinic

Transplant Infectious Disease | May 25, 2022 | Volume: 24 | Issue: 4 | Pages: No page available

10.1111/tid.13865 | PMID 35612090 Get It

How are patient-related characteristics associated with shared decision-making about treatment? A scoping review of quantitative studies
Keij, Sascha M. , Boer, Joyce E. de, Bruin, Wändi Bruine de , Moaddine, Saïda, Kunneman, Marleen , Pieterse, Arwen H. , Pieterse, Arwen H , Stiggelbout, Anne M. , Peters, Ellen M.

Mayo Clinic

BMJ Open | May 25, 2022 | Volume: 12 | Issue: 5 | Pages: e057293

10.1136/bmjopen-2021-057293 | PMID 35613791 Get It

Objectives To identify what patient-related characteristics have been reported to be associated with the occurrence of shared decision-making (SDM) about treatment. Design Scoping review. Eligibility criteria Peer-reviewed articles in English or Dutch reporting on associations between patient-related characteristics and the occurrence of SDM for actual treatment decisions. Information sources COCHRANE Library, Embase, MEDLINE, PsycInfo, PubMed and Web of Science were systematically searched for articles published until 25 March 2019. Results The search yielded 5289 hits of which 53 were retained. Multiple categories of patient characteristics were identified: (1) sociodemographic characteristics (eg, gender), (2) general health and clinical characteristics (eg, symptom severity), (3) psychological characteristics and coping with illness (eg, self-efficacy) and (4) SDM style or preference. Many characteristics showed no association or unclear relationships with SDM occurrence. For example, for female gender positive, negative and, most frequently, non-significant associations were seen. Conclusions A large variety of patient-related characteristics have been studied, but for many the association with SDM occurrence remains unclear. The results will caution often-made assumptions about associations and provide an important step to target effective interventions to foster SDM with all patients.
Looking ahead: giant-cell arteritis in 10 years time
Bond, Milena , Tomelleri, Alessandro , Buttgereit, Frank , Matteson, Eric L. , Dejaco, Christian , Dejaco, Christian , Buttgereit, Frank

Mayo Clinic

Therapeutic Advances in Musculoskeletal Disease | May 25, 2022 | Volume: 14 | Issue: No issue available | Pages: No page available

10.1177/1759720x221096366 | PMID 35634351 Get It

Although great improvements have been achieved in the fields of diagnosing and treating patients with giant-cell arteritis (GCA) in the last decades, several questions remain unanswered. The progressive increase in the number of older people, together with growing awareness of the disease and use of advanced diagnostic tools by healthcare professionals, foretells a possible increase in both prevalence and number of newly diagnosed patients with GCA in the coming years. A thorough clarification of pathogenetic mechanisms and a better definition of clinical subsets are the first steps toward a better understanding of the disease and, subsequently, toward a better use of existing and future therapeutic options. Examination of the role of different imaging techniques for GCA diagnosing and monitoring, optimization, and personalization of glucocorticoids and other immunosuppressive agents, further development and introduction of novel drugs, identification of prognostic factors for long-term outcomes and management of treatment discontinuation will be the central topics of the research agenda in years to come.
Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity
Dragojevic, Sonja , Ryu, Jung Su , Hall, Michael E. , Raucher, Dražen

Mayo Clinic

Molecules | May 25, 2022 | Volume: 27 | Issue: 11 | Pages: 3371

10.3390/molecules27113371 | PMID 35684309 Get It

The anticancer agent doxorubicin(dox) has been widely used in the treatment of a variety of hematological malignancies and solid tumors. Despite doxorubicin’s efficiency in killing tumor cells, severe damage to healthy tissues, along with cardiotoxicity, limits its clinical use. To overcome these adverse side effects, improve patient safety, and enhance therapeutic efficacy, we have designed a thermally responsive biopolymer doxorubicin carrier that can be specifically targeted to tumor tissue by locally applying mild hyperthermia (41 °C). The developed drug vehicle is composed of the following: a cell penetrating peptide (SynB1) to promote tumor and cellular uptake; thermally responsive Elastin-like polypeptide (ELP); and the (6-maleimidocaproyl) hydrazone derivative of doxorubicin (DOXO-EMCH) containing a pH-sensitive hydrazone linker that releases doxorubicin in the acidic tumor environment. We used the in vivo imaging system, IVIS, to determine biodistribution of doxorubicin-delivered ELP in MDA-MB-231 xenografts in nude mice. Tumor bearing mice were treated with a single IV injection of 10 mg/kg doxorubicin equivalent dose with free doxorubicin, thermally responsive SynB1 ELP 1-DOXO, and a thermally nonresponsive control biopolymer, SynB1 ELP 2-DOXO. Following a 2 h treatment with hyperthermia, tumors showed a 2-fold higher uptake when treated with SynB1 ELP 1-DOXO compared to free doxorubicin. Accumulation of the thermally non-responsive control SynB1 ELP2 –DOXO was comparable to free doxorubicin, indicating that an increase in dox accumulation with ELP is due to aggregation in response to thermal targeting. Higher levels of SynB1 ELP1–DOXO and SynB1 ELP2 –DOXO with respect to free doxorubicin were observed in kidneys. Fluorescence intensity from hearts of animals treated with SynB1 ELP1–DOXO show a 5-fold decrease in accumulation of doxorubicin than the same dose of free doxorubicin. SynB1-ELP1-DOXO biopolymers demonstrated a 6-fold increase in tumor/heart ratio in comparison to free doxorubicin, indicating preferential accumulation of the drug in tumors. These results demonstrate that thermally targeted polymers are a promising therapy to enhance tumor targeting and uptake of anticancer drugs and to minimize free drug toxicity in healthy tissues, representing a great potential for clinical application.